Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degraders
Jayapal Reddy Mallareddy(University of Nebraska Medical Center), Aaron S. Mansfield(Mayo Clinic), Janet Schaefer-Klein(Mayo Clinic), Sandeep Rana(National Center for Advancing Translational Sciences), Mitesh J. Borad(Jacksonville College), Jennifer Ayers-Ringler(Mayo Clinic), Sydney P. Kubica(Nebraska Medical Center), Amarnath Natarajan(University of Nebraska Medical Center), Anja C. Roden(Mayo Clinic), Smitha Kizhake(Nebraska Medical Center), Ezequiel J. Tolosa(Mayo Clinic), Sophie Alvarez(Abterra Biosciences (United States)), Ryan W. Feathers(Mayo Clinic in Florida), Lidia Boghean(Nebraska Medical Center), Michael J. Naldrett(University of Nebraska–Lincoln), Farhad Kosari(Mayo Clinic), Wan‐Hsin Lin(Mayo Clinic in Florida), Amritha G. Kizhake(Nebraska Medical Center), Sarbjit Singh(Nebraska Medical Center), Panos Z. Anastasiadis(Mayo Clinic in Florida), Lin Yang(Mayo Clinic), Muhammad Zahid(Nebraska Medical Center)
Cited by 2
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969